杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/10/26 | 1,768 | 1,783 | 1,749 | 1,753 | -15 | -0.8% | 108,500 |
2023/10/25 | 1,795 | 1,795 | 1,768 | 1,768 | -14 | -0.8% | 108,200 |
2023/10/24 | 1,781 | 1,785 | 1,758 | 1,782 | -6 | -0.3% | 78,800 |
2023/10/23 | 1,785 | 1,800 | 1,777 | 1,788 | +3 | +0.2% | 58,300 |
2023/10/20 | 1,791 | 1,797 | 1,772 | 1,785 | -8 | -0.4% | 56,900 |
2023/10/19 | 1,778 | 1,803 | 1,778 | 1,793 | +4 | +0.2% | 66,100 |
2023/10/18 | 1,787 | 1,796 | 1,767 | 1,789 | +2 | +0.1% | 90,600 |
2023/10/17 | 1,782 | 1,793 | 1,775 | 1,787 | +5 | +0.3% | 52,000 |
2023/10/16 | 1,808 | 1,810 | 1,781 | 1,782 | -24 | -1.3% | 43,600 |
2023/10/13 | 1,819 | 1,833 | 1,798 | 1,806 | -28 | -1.5% | 71,200 |
2023/10/12 | 1,840 | 1,840 | 1,820 | 1,834 | -6 | -0.3% | 55,600 |
2023/10/11 | 1,833 | 1,847 | 1,822 | 1,840 | +9 | +0.5% | 82,700 |
2023/10/10 | 1,800 | 1,834 | 1,800 | 1,831 | +19 | +1% | 79,400 |
2023/10/06 | 1,793 | 1,829 | 1,793 | 1,812 | +6 | +0.3% | 68,400 |
2023/10/05 | 1,780 | 1,809 | 1,777 | 1,806 | +15 | +0.8% | 85,100 |
2023/10/04 | 1,794 | 1,813 | 1,780 | 1,791 | -21 | -1.2% | 81,600 |
2023/10/03 | 1,821 | 1,836 | 1,812 | 1,812 | -2 | -0.1% | 89,300 |
2023/10/02 | 1,847 | 1,850 | 1,814 | 1,814 | -17 | -0.9% | 105,800 |
2023/09/29 | 1,855 | 1,858 | 1,817 | 1,831 | -22 | -1.2% | 87,000 |
2023/09/28 | 1,831 | 1,863 | 1,819 | 1,853 | -10 | -0.5% | 149,800 |
2023/09/27 | 1,833 | 1,864 | 1,819 | 1,863 | +28 | +1.5% | 122,100 |
2023/09/26 | 1,830 | 1,845 | 1,820 | 1,835 | +11 | +0.6% | 90,400 |
2023/09/25 | 1,800 | 1,830 | 1,791 | 1,824 | +42 | +2.4% | 133,800 |
2023/09/22 | 1,796 | 1,803 | 1,780 | 1,782 | -26 | -1.4% | 78,500 |
2023/09/21 | 1,806 | 1,824 | 1,803 | 1,808 | +1 | +0.1% | 67,300 |
2023/09/20 | 1,834 | 1,834 | 1,805 | 1,807 | -27 | -1.5% | 102,400 |
2023/09/19 | 1,815 | 1,834 | 1,815 | 1,834 | +3 | +0.2% | 58,500 |
2023/09/15 | 1,812 | 1,842 | 1,801 | 1,831 | +24 | +1.3% | 217,700 |
2023/09/14 | 1,800 | 1,810 | 1,790 | 1,807 | +8 | +0.4% | 110,800 |
2023/09/13 | 1,800 | 1,801 | 1,789 | 1,799 | -1 | -0.1% | 68,500 |
2023/09/12 | 1,779 | 1,802 | 1,778 | 1,800 | +22 | +1.2% | 55,200 |
2023/09/11 | 1,773 | 1,780 | 1,764 | 1,778 | +4 | +0.2% | 41,400 |
2023/09/08 | 1,783 | 1,795 | 1,771 | 1,774 | -7 | -0.4% | 102,700 |
2023/09/07 | 1,775 | 1,785 | 1,770 | 1,781 | -1 | -0.1% | 83,600 |
2023/09/06 | 1,798 | 1,798 | 1,776 | 1,782 | -9 | -0.5% | 42,600 |
2023/09/05 | 1,787 | 1,800 | 1,779 | 1,791 | +2 | +0.1% | 84,200 |
2023/09/04 | 1,788 | 1,792 | 1,775 | 1,789 | -5 | -0.3% | 60,600 |
2023/09/01 | 1,773 | 1,797 | 1,766 | 1,794 | +20 | +1.1% | 130,700 |
2023/08/31 | 1,766 | 1,776 | 1,765 | 1,774 | +5 | +0.3% | 159,500 |
2023/08/30 | 1,769 | 1,778 | 1,763 | 1,769 | -1 | -0.1% | 74,900 |
2023/08/29 | 1,749 | 1,770 | 1,748 | 1,770 | +21 | +1.2% | 75,500 |
2023/08/28 | 1,755 | 1,758 | 1,745 | 1,749 | +4 | +0.2% | 32,400 |
2023/08/25 | 1,736 | 1,753 | 1,732 | 1,745 | +6 | +0.3% | 92,000 |
2023/08/24 | 1,731 | 1,745 | 1,727 | 1,739 | -1 | -0.1% | 42,500 |
2023/08/23 | 1,724 | 1,743 | 1,724 | 1,740 | +4 | +0.2% | 45,300 |
2023/08/22 | 1,735 | 1,741 | 1,725 | 1,736 | +2 | +0.1% | 52,100 |
2023/08/21 | 1,734 | 1,741 | 1,728 | 1,734 | +6 | +0.3% | 50,500 |
2023/08/18 | 1,711 | 1,729 | 1,710 | 1,728 | +15 | +0.9% | 62,300 |
2023/08/17 | 1,728 | 1,731 | 1,712 | 1,713 | -15 | -0.9% | 103,900 |
2023/08/16 | 1,732 | 1,735 | 1,718 | 1,728 | -16 | -0.9% | 114,100 |
351~
400
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 143,100円 | +3.2% | +4.5% | 3.63% | 16.44倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
サンバイオ | 162,700円 | - | - | 0.00% | - | 75.36倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
持田薬 | 301,500円 | +3.0% | +27.5% | 2.65% | 19.09倍 | 0.83倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 174,100円 | +21.7% | +999.9% | 0.00% | 7.25倍 | 2.40倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
栄研化 | 213,600円 | +0.4% | -8.4% | 2.48% | 27.42倍 | 1.55倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム